These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30001348)

  • 21. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy.
    Guey S; Grangeon L; Brunelle F; Bergametti F; Amiel J; Lyonnet S; Delaforge A; Arnould M; Desnous B; Bellesme C; Hervé D; Schwitalla JC; Kraemer M; Tournier-Lasserve E; Kossorotoff M
    J Med Genet; 2017 Aug; 54(8):550-557. PubMed ID: 28343148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
    Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
    PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy.
    Lee ML; Chang TM; Yang RC; Yang AD; Chen M
    Turk J Pediatr; 2019; 61(4):629-634. PubMed ID: 31990487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.
    Kundishora AJ; Peters ST; Pinard A; Duran D; Panchagnula S; Barak T; Miyagishima DF; Dong W; Smith H; Ocken J; Dunbar A; Nelson-Williams C; Haider S; Walker RL; Li B; Zhao H; Thumkeo D; Marlier A; Duy PQ; Diab NS; Reeves BC; Robert SM; Sujijantarat N; Stratman AN; Chen YH; Zhao S; Roszko I; Lu Q; Zhang B; Mane S; Castaldi C; López-Giráldez F; Knight JR; Bamshad MJ; Nickerson DA; Geschwind DH; Chen SL; Storm PB; Diluna ML; Matouk CC; Orbach DB; Alper SL; Smith ER; Lifton RP; Gunel M; Milewicz DM; Jin SC; Kahle KT
    JAMA Neurol; 2021 Aug; 78(8):993-1003. PubMed ID: 34125151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
    Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R
    Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West.
    Raso A; Biassoni R; Mascelli S; Nozza P; Ugolotti E; Di Marco E; De Marco P; Merello E; Cama A; Pavanello M; Capra V
    J Neurosurg Sci; 2020 Apr; 64(2):165-172. PubMed ID: 27787485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.
    Darrigo Júnior LG; Valera ET; Machado Ade A; Santos AC; Scrideli CA; Tone LG
    Sao Paulo Med J; 2011 Mar; 129(2):110-2. PubMed ID: 21603789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.
    Guey S; Kraemer M; Hervé D; Ludwig T; Kossorotoff M; Bergametti F; Schwitalla JC; Choi S; Broseus L; Callebaut I; Genin E; Tournier-Lasserve E;
    Eur J Hum Genet; 2017 Aug; 25(8):995-1003. PubMed ID: 28635953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
    Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
    PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and Environmental Associations With Pediatric Cerebral Arteriopathy.
    McCrea N; Fullerton HJ; Ganesan V
    Stroke; 2019 Feb; 50(2):257-265. PubMed ID: 30661495
    [No Abstract]   [Full Text] [Related]  

  • 31. Adult-onset Moyamoya disease in a patient with neurofibromatosis type 1.
    Jiménez Caballero PE
    Neurologia; 2016 Mar; 31(2):139-41. PubMed ID: 24801636
    [No Abstract]   [Full Text] [Related]  

  • 32. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
    Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
    World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scoliosis Secondary to Neurofibromatosis Type I Combined With Moyamoya Syndrome: A Case Report.
    Zhang H; Luo Y; Guo D; Yao Z; Liu H; Zhang X
    JBJS Case Connect; 2022 Jul; 12(3):. PubMed ID: 36137072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xq28 copy number gain causing moyamoya disease and a novel moyamoya syndrome.
    Aloui C; Guey S; Pipiras E; Kossorotoff M; Guéden S; Corpechot M; Bessou P; Pedespan JM; Husson M; Hervé D; Riant F; Kraemer M; Steffann J; Quenez O; Tournier-Lasserve E
    J Med Genet; 2020 May; 57(5):339-346. PubMed ID: 31924698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.
    D'Amico A; Ugga L; Cocozza S; Giorgio SMDA; Cicala D; Santoro C; Melis D; Cinalli G; Brunetti A; Pappatà S
    Neurol Sci; 2021 Feb; 42(2):655-663. PubMed ID: 32651859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis.
    Erickson RP; Woolliscroft J; Allen RJ
    Clin Genet; 1980 Sep; 18(3):191-6. PubMed ID: 6777096
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurofibromatosis type 1 association with moyamoya disease.
    Koc F; Yerdelen D; Koc Z
    Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mystery(n) Phenotypic Presentation in Europeans: Report of Three Further Novel Missense
    Santoro C; Mirone G; Zanobio M; Ranucci G; D'Amico A; Cicala D; Iascone M; Bernardo P; Piccolo V; Ronchi A; Limongelli G; Carotenuto M; Nigro V; Cinalli G; Piluso G
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.